Encouraging data from CDC, Moderna reassures about vaccine efficacy against B117 strain, and Merck shelves its COVID-19 vaccines after disappointing Phase 1.
COVID-19 data trending slightly down
COVID-19 data trending slightly down
COVID-19 data trending slightly down
Encouraging data from CDC, Moderna reassures about vaccine efficacy against B117 strain, and Merck shelves its COVID-19 vaccines after disappointing Phase 1.